Publications by authors named "Myriam Merzoug"
Article Synopsis
- Anemia is a common issue in patients with end-stage kidney disease (ESKD), and current treatments include erythropoiesis-stimulating agents and intravenous (IV) iron.
- A study compared the liver accumulation of iron from IV iron sucrose versus two newer options, ferric carboxymaltose and iron isomaltoside, in dialysis patients.
- Results showed that IV iron sucrose significantly increased liver iron concentration, while the newer agents had much less impact, indicating they may be safer for treating anemia in ESKD.
